STENIPATH
Financiado
Stem and niche cell dynamics in normal and pathological conditions
Coherent tissue growth and repair require an interplay between stem cells and their local and systemic environment. The dynamics of this process remains poorly defined particularly at the intersection with disease. Cellular quiesc...
Coherent tissue growth and repair require an interplay between stem cells and their local and systemic environment. The dynamics of this process remains poorly defined particularly at the intersection with disease. Cellular quiescence is adopted by many adult stem cells, conferring them several features including a smaller cell volume and reduced metabolic demand, suggesting that quiescence preserves stem cell properties making them less responsive to external cues. We examined the status of skeletal muscle stem (MuSC) and niche cells during an influenza virus infection (lung) and cancer cachexia (tumour) in mice. Unexpectedly, quiescent MuSCs remodelled their cellular, metabolic, and transcriptome properties extensively, and tissue regeneration was impaired, prompting us to define a novel cell state, GPath. Whether GPath represents a coordinated response of stem cells to pathology, or uncontrolled deregulation, is unclear.
MuSCs exhibit remarkable diversity in gene regulation and function in distinct anatomical locations (head/limb). We discovered that cranial MuSCs display higher resistance to the pathologies compared to those in limb. These observations have led us into a novel area of research, to the best of my knowledge largely unexplored in model organisms and humans: how stem and niche cells in one organ respond to pathologies present at a distal site. We will examine the response of muscle and blood stem and niche cells to distal pathologies by defining their cellular, metabolic, molecular, epigenetic, and functional properties, and their modes of cell division. We will employ diverse multiomics approaches and novel medium/high-throughput intravital and ex vivo imaging pipelines. This work should provide new knowledge and tools to address an important, but under-investigated area of research where stem cell biology and pathologies converge. The knowledge gained will be widely applicable to other stem cell systems and inform on human pathologies.
ver más
Duración del proyecto: 60 meses
Fecha Inicio: 2022-08-30
Fecha Fin: 2027-08-31
Fecha Fin: 2027-08-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-08-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
ERC-2021-ADG:
ERC ADVANCED GRANTS
Cerrada
hace 3 años
Presupuesto
El presupuesto total del proyecto asciende a
2M€
Líder del proyecto
INSTITUT PASTEUR
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5